semaglutide oral approval Novo Nordisk has announced that the FDA has approved the Wegovy® pill (once-daily 25 mg) as the first ever oral GLP-1 receptor agonist therapy for chronic weight management in adults Business | Novo Nordisk has
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26





















